These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31211392)

  • 21. Reductions in resistance exercise-induced hyperglycaemic episodes are associated with circulating interleukin-6 in type 1 diabetes.
    Turner D; Luzio S; Kilduff LP; Gray BJ; Dunseath G; Bain SC; Campbell MD; West DJ; Bracken RM
    Diabet Med; 2014 Aug; 31(8):1009-13. PubMed ID: 24702172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function.
    Taylor GS; Smith K; Capper TE; Scragg JH; Bashir A; Flatt A; Stevenson EJ; McDonald TJ; Oram RA; Shaw JA; West DJ
    Diabetes Care; 2020 Oct; 43(10):2362-2370. PubMed ID: 32747405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise-induced hypoglycaemia and subcutaneous insulin infusion.
    Edelmann E; Staudner V; Bachmann W; Walter H; Haas W; Mehnert H
    Diabet Med; 1986; 3(6):526-31. PubMed ID: 2951207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Rickels MR; DuBose SN; Toschi E; Beck RW; Verdejo AS; Wolpert H; Cummins MJ; Newswanger B; Riddell MC;
    Diabetes Care; 2018 Sep; 41(9):1909-1916. PubMed ID: 29776987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute, same-day effects of antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes mellitus.
    Sandoval DA; Guy DL; Richardson MA; Ertl AC; Davis SN
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1331-8. PubMed ID: 16449302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting specific interstitial glycemic parameters with high-intensity interval exercise and fasted-state exercise in type 2 diabetes.
    Terada T; Wilson BJ; Myette-Côté E; Kuzik N; Bell GJ; McCargar LJ; Boulé NG
    Metabolism; 2016 May; 65(5):599-608. PubMed ID: 27085769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study.
    Ivandic M; Cigrovski Berkovic M; Ormanac K; Sabo D; Omanovic Kolaric T; Kuna L; Mihaljevic V; Canecki Varzic S; Smolic M; Bilic-Curcic I
    Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.
    Steineck IIK; Ranjan A; Schmidt S; Clausen TR; Holst JJ; Nørgaard K
    Diabetologia; 2019 Apr; 62(4):582-592. PubMed ID: 30643924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of midday moderate-intensity exercise on postexercise hypoglycemia risk in individuals with type 1 diabetes.
    Davey RJ; Howe W; Paramalingam N; Ferreira LD; Davis EA; Fournier PA; Jones TW
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2908-14. PubMed ID: 23780373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of morning hypoglycemia on neuroendocrine and metabolic responses to subsequent afternoon hypoglycemia in normal man.
    Davis SN; Tate D
    J Clin Endocrinol Metab; 2001 May; 86(5):2043-50. PubMed ID: 11344204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes.
    Maran A; Pavan P; Bonsembiante B; Brugin E; Ermolao A; Avogaro A; Zaccaria M
    Diabetes Technol Ther; 2010 Oct; 12(10):763-8. PubMed ID: 20807120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal effect of walking before dinner on glycemic responses in type 2 diabetes: outcomes from the multi-site E-PAraDiGM study.
    Rees JL; Chang CR; François ME; Marcotte-Chénard A; Fontvieille A; Klaprat ND; Dyck RA; Funk DR; Snydmiller G; Bastell K; Godkin FE; Dubé MC; Riesco E; McGavock JM; Yardley JE; Sigal RJ; Gibala MJ; Weisnagel SJ; Prado CM; Jung M; Manders R; Lee T; Singer J; Boulé NG; Little JP
    Acta Diabetol; 2019 Jul; 56(7):755-765. PubMed ID: 31093764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol and postexercise metabolic responses in type 2 diabetes.
    Rasmussen BM; Christiansen C; Rasmussen OW; Hansen C; Hermansen K
    Metabolism; 1999 May; 48(5):597-602. PubMed ID: 10337860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vigorous Intervals and Hypoglycemia in Type 1 Diabetes: A Randomized Cross Over Trial.
    Rempel M; Yardley JE; MacIntosh A; Hay JL; Bouchard D; Cornish S; Marks SD; Hai Y; Gordon JW; McGavock J
    Sci Rep; 2018 Oct; 8(1):15879. PubMed ID: 30367116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: Results from the TREAD-DIAB study.
    Moniotte S; Owen M; Barrea T; Robert A; Lysy PA
    Pediatr Diabetes; 2017 Dec; 18(8):925-933. PubMed ID: 28251726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
    Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
    Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.